Acacia unit, Boston Sci settle patent spat; Spectranetics names Scott Drake as next CEO;

> Acacia Research Corporation's EVM Systems subsidiary has entered into a settlement agreement with Boston Scientific regarding patents for shape memory metal medical instruments. The settlement agreement resolves litigation that was pending in the Eastern District of Texas. Acacia release

> Spectranetics has announced the appointment of Scott Drake as president and CEO, effective Aug. 10. Spectranetics release

> B. Braun Medical has acquired U.S. patent 7,933,780, which was issued April 26, 2011, and two pending applications, providing the company patent rights related to enhanced communication between medical devices and hospital information management systems through wireless communication. B. Braun release

> InfraReDx today announced enrollment of the first patient in its Phase II clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow). CANARY is designed to test the hypothesis that NIR-guided use of an embolic protection device during percutaneous coronary intervention can reduce the rate of peri-procedural heart attacks in patients identified as having high-risk lipid core plaques. InfraReDx release

> Roche and Caliper Life Sciences have announced a co-marketing agreement for the development and optimization of automated protocols for the NimbleGen SeqCap EZ Library solution-based capture method for Caliper's Sciclone NGS Workstation. Roche NimbleGen release

And Finally... A diabetes blog offers an interesting interview with a Medtronic executive about product design, and whom the company tailors its products for (hint: it's not the patient). Piece

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.